Emergency Contraceptive Pills Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Emergency Contraceptive Pills Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

A recent report on the global emergency contraceptive pills market predicts a subdued growth trajectory over the next five years. From 2024 to 2031, the market is anticipated to experience lackluster expansion.

Factors Dampening Emergency Contraceptive Pill Sales

Several factors are expected to impede the sales of emergency contraceptive pills during the forecast period. Challenges such as time constraints associated with pill intake and potential side effects contribute to this trend.

North America Emerges as the Leading Market

North America is projected to emerge as the largest market for emergency contraceptive pills. Organizations like the International Consortium for Emergency Contraception, based in the United States, are actively promoting the use of emergency contraceptive pills, contributing to the region's dominance.

Combination Pills Maintain Steady Growth

Among the products in the global emergency contraceptive pills market, combination pills are expected to maintain relatively steady growth. These pills are effective in reducing the risk of ectopic pregnancy, ovarian cancer, and premenstrual tension. In 2023, combination pills are estimated to hold approximately 40% of the global market share.

Decline in Demand for Estrogen and Progesterone Pills

In contrast, the demand for estrogen pills is expected to decline rapidly, and by 2031, progesterone pills are also anticipated to lose traction. Side effects such as breast pain, hot flashes, diarrhea, and joint pain associated with progesterone pills are likely to contribute to reduced sales.

Hospital Pharmacies and Drug Stores Dominate Sales Channels

The growth of the global emergency contraceptive pills market will mainly be driven by revenues generated from hospital pharmacies and drug stores. These two sales channels are expected to collectively account for over three-fifths of global revenues. On the other hand, online sales of emergency contraceptive pills are projected to decline, primarily due to the 72-hour time constraint associated with their intake.

Leading Players in the Market

The report profiles key players in the global emergency contraceptive pills market, including Bayer AG, Teva Pharmaceutical Industries Ltd., Piramal Enterprises Limited, HRA Pharma, Mankind Pharma Ltd., Lupin Limited, Richter Gedeon Nyrt, Cooper Pharma, Zhejiang Xianju Pharmaceutical Co., and Pfizer Inc. These manufacturers are expected to focus on research and development to create pills with minimal side effects.

Market Segmentation

Product Type
• Combination Pills
• Progesterone Pills
• Estrogen Pills
• Other Products

Sales Channel
• Drug Stores/ Pharmacy
• Hospital Pharmacies
• Online Traders
• Other Channels

Region
• North America
• Latin America
• Europe
• Japan
• APEJ
• MEA

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.